News

HHS slams 'under-tested' mRNA technology as Trump cuts Moderna's vaccine funding
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...
HHS cuts funding for bird flu vaccine trials
The Trump administration canceled $766 million in funding to drugmaker Moderna for development of a vaccine against potential ...
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
Moderna, Inc. (NASDAQ:MRNA) announced today that its investigational H5 avian influenza vaccine, mRNA-1018, has shown ...
Trump administration cuts $766 million in funding to Moderna for bird flu, pandemic vaccine projects
The Trump administration has withdrawn $766 million in funding from Moderna, impacting the development of vaccines against ...
Devdiscourse9d
Funding Cut for Moderna’s Pandemic Vaccine Sparks Controversy
The Trump administration has withdrawn $766 million allocated to Moderna Inc for developing a pandemic flu vaccine. Despite ...
Trump administration yanks Moderna's bird flu vaccine research funding even as company reports promising test results
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
US cancels more than $700 million funding for Moderna bird flu vaccine
The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine ...
HHS cancels funding for Moderna to develop vaccines to combat bird flu
The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...
HHS pulls millions in funding for Moderna to develop bird flu vaccines
The Trump administration canceled the grants this week, citing concerns that novel mRNA vaccine technology remains “under-tested,” posing a risk to public health.
Indiatimes9d
Trump administration cuts $766 million in funding to Moderna for bird flu, pandemic vaccine projects
The Trump administration has withdrawn $766 million in funding from Moderna, impacting the development of vaccines against potential pandemic influenza viruses, including H5N1 bird flu.